Sun Pharmaceutical Industries Limited (BOM:524715)
India · Delayed Price · Currency is INR | Market Cap | 3.92T |
| Revenue (ttm) | 549.64B |
| Net Income (ttm) | 104.50B |
| Shares Out | n/a |
| EPS (ttm) | 43.55 |
| PE Ratio | 37.52 |
| Forward PE | 31.26 |
| Dividend | 16.00 (0.98%) |
| Ex-Dividend Date | Jul 7, 2025 |
| Volume | 116,302 |
| Average Volume | 161,022 |
| Open | 1,613.00 |
| Previous Close | 1,612.55 |
| Day's Range | 1,613.00 - 1,647.25 |
| 52-Week Range | 1,547.25 - 1,850.95 |
| Beta | n/a |
| RSI | 32.85 |
| Earnings Date | Jan 31, 2026 |
About BOM:524715
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsychiatry, cardiology, diabetes, gastroenterology, pain/analgesics, gynecology, ophthalmology, urology, dermatology, respiratory, anti-infectives, oncology, psychiatry, neurology, orthopaedic, nephrology, urology, dermatology, respira... [Read more]
Financial Performance
In 2024, BOM:524715's revenue was 525.78 billion, an increase of 8.42% compared to the previous year's 484.97 billion. Earnings were 109.29 billion, an increase of 14.12%.
Financial StatementsNews
Sun Pharma Gains Approval for Generic Wegovy in India
Sun Pharma Gains Approval for Generic Wegovy in India
Sun Pharma cleared to sell generic Wegovy, intensifying India’s obesity-drug race with Novo Nordisk
Sun Pharma gets DCGI nod to manufacture and market generic semaglutide injection in India
Sun Pharmaceutical Industries Limited has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a...
Pharma sector stocks today: Senores up 1.79%, Lupin rises 1%, Sun Pharma jumps 0.81%,
The Indian pharma sector stocks showed mixed performance as of 10:22 AM IST on January 21, 2026. Broader market context...
Sun Pharma Eyes Organon In What Could Be India Pharma's Biggest Cross-Border Deal: Report
India-based Sun Pharmaceutical Industries Ltd is reportedly evaluating a potential acquisition of Organon & Co (NYSE: OGN), a U.S.-based women's healthcare company. If it goes through, the deal that ...
Organon (OGN) Shares Surge on Acquisition Offer from Sun Pharma
Organon (OGN) Shares Surge on Acquisition Offer from Sun Pharma
Organon gains on report of Sun Pharmaceutical interest
Pharma sector stocks fall today: Glenmark Pharma drops 1.38%, Aurobindo Pharma downm 1.25%, Sun Pharma falls 0.87, Dr. Reddy’s Lab down 0.48%
The pharma sector stocks in India experienced declines as of 10 AM on January 20, 2026, aligning with broader market...
Pharma sector stocks today: Sun Pharma falls 1.43%, Ipca Labs down 1.32%, Alembic Pharma drops 1.08%
The Indian pharmaceutical sector showed mixed performance on January 16, 2026, as of around 10 AM IST. Broader market indices...
Top stocks to watch today, January 16: Infosys, Sun Pharma, BHEL, ICICI Prudential, HDFC Life and more
Indian equity benchmark indices are likely to open on a flat note on Friday, tracking mixed global cues and subdued...
Nifty 50 top losers today, January 14 :Asian Paints, TCS, Maruti Suzuki India, Tech Mahindra, Sun Pharma and more
Indian equity benchmarks closed lower in a volatile session on January 14, 2026, with selling pressure visible across several heavyweights....
Pharma sector stocks today: Sun Pharma falls 1.20%, Lupin down 1%, Glenmark Pharma rises 0.49%
The Indian pharma sector showed modest downward pressure in early trading on January 14, 2026, as of approximately 9:55 AM...
Pharma sector stocks down today: Divi’s Laboratories falls nearly 3%, Biocon drops 1.09%, Sun Pharma down 0.45%
The Indian pharmaceutical sector experienced downward pressure on January 12, 2026, amid broader market trends. The S&P BSE Healthcare index...
Palvella Therapeutics Strengthens Leadership Team with Appointment of Veteran Medical Affairs Leader Vimal Patel, PharmD, as Senior Vice President of Medical Affairs
Seasoned dermatology and immunology executive brings more than 25 years of experience advancing and launching innovative therapies, including OPZELURA ® , povorcitinib, ILUMYA®, ODOMZO ® , REMICADE ® ...
Pharma generics: Semaglutide patent expiry to open Rs 50bn opportunity; Indian players eye FY27 boost
Semaglutide patent expiries in India, Canada, and Brazil are poised to unlock over Rs 50 billion in revenue for generic drugmakers within 12-15 months. Indian companies like Alkem, Dr Reddy's, and Sun...
Dr Reddy, Cipla, Sun Pharma and other stocks in focus today as Govt bans high-dose Nimesulide formulations
Shares of several pharmaceutical companies are likely to remain in focus after the Ministry of Health and Family Welfare (MoHFW)...
Sun Pharma may face low double-digit EPS hit in worst case, says Kotak
Kotak Institutional Equities has maintained its add rating on Sun Pharma with a target price of ₹1,975, warning that newly...
Nifty 50 top losers today, December 18: Sun Pharma, Tata Steel, Power Grid, Asian Paints, Tata Consumer Products and more
Indian equity benchmarks closed marginally lower after a volatile trading session on December 18, with selling pressure in several heavyweight...
Sun Pharma shares fall over 2% after US FDA issues OAI status for Baska facility
Sun Pharmaceutical Industries’ shares slipped more than 2% after the company disclosed that the US Food and Drug Administration (US...
Sun Pharma receives US FDA OAI status for Baska facility after Inspection
Sun Pharmaceutical Industries Ltd has informed the stock exchanges that the US Food and Drug Administration (US FDA) has classified...
Nifty 50 top losers today, December 12: Hindustan Unilever, Max Healthcare Institute, Sun Pharma, ITC, Asian Paints and more
Indian equity indices ended Thursday’s session on a steady positive note, with the Nifty closing 0.57% higher at 26,046.95 and...
Nifty 50 top gainers today, December 10: Eicher Motors, Hindalco Industries, HDFC Life, Tata Steel, Sun Pharma and more
Indian equity benchmarks closed lower on December 10, with the Nifty settling at 25,758 and the Sensex declining 275 points...
Novo Nordisk moves Delhi HC to bar Sun Pharma from manufacturing semaglutide; Hearing expected tomorrow
Danish drugmaker Novo Nordisk has approached the Delhi High Court seeking to restrain Sun Pharmaceutical Industries from manufacturing semaglutide, a...
Sun Pharma shares in focus as Novo Nordisk moves HC to block firm from manufacturing semaglutide
Shares of Sun Pharmaceutical Industries were trading mildly lower on Monday, slipping 0.42% to Rs 1,788.70 as of 11:08 AM,...
Nifty 50 top losers today, December 1: Max Healthcare, InterGlobe Aviation, Bajaj Finance, Sun Pharma, Adani Enterprises and more
Indian equity benchmarks spent much of the December 1 session moving within a narrow band, eventually closing almost unchanged. The...